News & Updates

Early gestational diabetes treatment modest at best in preventing adverse neonatal outcomes
Early gestational diabetes treatment modest at best in preventing adverse neonatal outcomes
09 Aug 2023

Treatment of gestational diabetes before 20 weeks’ gestation appears to lead to a modestly lower incidence of a composite of adverse neonatal outcomes as compared with no-immediate treatment, with no substantial differences noted for pregnancy-related hypertension or neonatal lean body mass, as reported in a study.

Early gestational diabetes treatment modest at best in preventing adverse neonatal outcomes
09 Aug 2023
Uncomplicated UTI: Choosing antibiotics based on resistance rates helps prevent treatment failure
Uncomplicated UTI: Choosing antibiotics based on resistance rates helps prevent treatment failure
08 Aug 2023 byJairia Dela Cruz

In the treatment of individuals with uncomplicated urinary tract infection (UTI), the use of antibiotics with lower reported resistance rates such as amoxicillin-clavulanate and nitrofurantoin (AC + N) lowers the rate of treatment failure, as shown in a study from Singapore.

Uncomplicated UTI: Choosing antibiotics based on resistance rates helps prevent treatment failure
08 Aug 2023
Frequent nut intake delays cognitive decline in older adults
Frequent nut intake delays cognitive decline in older adults
08 Aug 2023
Comorbid depression and sleep behaviour disorder puts patients and relatives at risk of neurodegeneration
Comorbid depression and sleep behaviour disorder puts patients and relatives at risk of neurodegeneration
08 Aug 2023 byKanas Chan

Comorbid major depressive disorder and rapid eye movement sleep behaviour disorder (MDD-RBD) is a common subtype of MDD. These patients and their first-degree relatives (FDRs) are at risk of neurodegeneration, researchers from the Chinese University of Hong Kong (CUHK) have reported.

Comorbid depression and sleep behaviour disorder puts patients and relatives at risk of neurodegeneration
08 Aug 2023